ANALYZING ASSORTMENT OF ANTIBIOTICS AND ANTIBACTERIAL MEDICINAL FORMS IN THE PHARMACEUTICAL MARKET OF THE REPUBLIC OF UZBEKISTAN

Author(s):  
N. M. Sultanbaeva
Author(s):  
Firuza Alisherovna Umarova ◽  
◽  
Kamal Saidakbarovich Rizaev ◽  
Nemat Kayumovich Olimov ◽  
Zaynab Enverovna Sidametova ◽  
...  

Analysis of the assortment of sedatives registered in the Republic of Uzbekistan showed that sedatives are represented on the pharmaceutical market of the country by such dosage forms as drops, solutions, tinctures, syrups, medicinal herbal raw materials, capsules and tablets. Considering that sedatives registered in the form of a substance, with the exception of the dry extract of Leoglycyrfl produced by “Uzkimyofarm”, there are practically no names of S.K. Islambekov in the Joint Stock Company. In this regard, we consider it expedient to create a new sedative medicinal product of herbal origin in the form of a substance and obtain dosage forms based on it.


2021 ◽  
Vol 92 (2) ◽  
pp. 33-39
Author(s):  
S. E. Rzheussky ◽  
◽  
P. S. Varabei ◽  

The article studies the domestic market of vasodilators for cardiac diseases in Belarus by analyzing and comparing secondary marketing information. The structure of the market depending on the manufacturing country was studied. It was established that medicines containing isosorbide mononitrate/dinitrate have the greatest number of indications to use and the least number of side effects. The dynamics of changing the sales of medicines in the vasodilators group for cardiac diseases for the period 2010-2018 is presented. The market attractiveness of medicines of the vasodilators group for cardiac diseases was studied using the matrix of the Boston Consulting Group (BCG matrix).


2021 ◽  
pp. 51-56
Author(s):  
А.Е. ЕСБОЛАТОВА ◽  
А.Р. ШОПАБАЕВА

Ассортимент фармацевтической продукции представляет собой большую непрерывно обновляемую структуру, являющейся одной из основных составных фрагментов системы здравоохранения каждого государства. В свою очередь, маркетинговый анализ противоглаукомных препаратов показывает состояние фармацевтического рынка препаратов, применяемых для лечения глаукомы, на исследуемый момент, что позволяет оценить дальнейшие перспективы развития и расширения рынка. The range of pharmaceutical products is a large continuously updated structure, which is one of the main constituent parts of the health care system of each state. In turn, the marketing analysis of antiglaucoma drugs shows the state of the pharmaceutical market for drugs used for the treatment of glaucoma at the moment under study, which makes it possible to assess further prospects for the development and expansion of the market.


2021 ◽  
Author(s):  
Samedinova Dilnoza Nuriddin qizi ◽  
Yunusova Kholida Mannanovna

Abstract In this study, we analysed, with the help of the “State Register of Medicines, Medical Devices and Medical Equipment Permitted for Use in Medical Practice of the Republic of Uzbekistan”, the number, dosage forms and cost of registered antiemetic drugs in 2016-2020 based on the DRUG AUDIT program, which offers a database of information from 2016 to 2020.


2021 ◽  
pp. 22-26
Author(s):  
Н.К. МАНАСОВ ◽  
У.М. ДАТХАЕВ ◽  
Б.Г. МАХАТОВА

Фармацевтический рынок Казахстана растет с каждым годом. Отечественные компании увеличивают внутренне производство ЛС и БАДов, что безусловно вносит свою лепту в решение проблемы импортозамещения. Однако стоит обратить внимание на более простые медикаменты, которыми наши граждане пользуются практически каждый день. К таким относятся ЛФ для рассасывания, которые купируют неприятные симптомы инфекционно - воспалительных заболеваний полости рта и горла, улучшая качество жизни. Стоит обратить внимание на этот сегмент рынка, который насчитывает млн. долларах США. Нами проведен подробный маркетинговый анализ рынка ЛФ для рассасывания Республики Казахстан. Представлены данные касательно лидеров рынка, доли зарубежных и отечественных производителей и объемов рынка за 2019-2020гг. The pharmaceutical market in Kazakhstan is growing every year. Domestic companies increase domestic production of drugs and dietary supplements, which certainly contributes to the problem of import substitution. However, it is worth to pay attention to simpler medicines, which our citizens use practically every day. Such drugs include liquids for resorption, which relieve unpleasant symptoms of infectious and inflammatory diseases of the mouth and throat, improving the quality of life. It is worth paying attention to this market segment, which amounts to millions of U.S. dollars. We have carried out a detailed marketing analysis of the dosage forms market for resorption in Republic of Kazakhstan. The data on the share of foreign and domestic manufacturers and market volumes for 2019-2020 are presented.


2018 ◽  
Vol 6 (2) ◽  
pp. 1-6
Author(s):  
Brunilda Myftari ◽  
Enxhi Andrea ◽  
Elton Myftari ◽  
Ledjan Malaj

Tablet division is a widespread phenomenon nowadays in Albania, because of different factors such as the absence of small dosages in the pharmaceutical market, financial reasons etc. The purpose of this study is to identify the positive and negative aspects of tablets division by patients. It aims to show experimentally if the division affects or not, in a significant way the percentage of the active substance. It was selected Amlodipine as a drug for analysis, because of two reasons. First it is used in chronic therapy and second it is part of the List of Reimbursement of Medicines in the Republic of Albania.It was used besylate amlodipine as RS, three different productions of Amlodipine tablets bought directly in a community pharmacy, methanol HPLC grade and ammonium acetate. It was selected the method based on the HPLC analysis of the solutions obtained by dissolution of amlodipine in methanol as described in the European Pharmacopoeia 2011. This was an ongoing analysis for four weeks. The divided tablets have been kept in similar conditions as a patient can do.The organoleptic control after division showed no changes for all three productions. Only halves of sample A fulfill the pharmacopoeia criteria for RD ± 7.5%. From the results obtained, it was noted that there was a decrease in the percentage of the active substance, on halves taken randomly for analysis. The concentration of the active substance in sample A at the end of the analysis resulted to be 83.6%, in sample B 84.37% and sample C 83.75%. The level of impurities remain ≤ 2% conform limits in Eur. Ph. Based on these results, it is concluded that tablet division is a process that significantly affects the percentage of the tablet's active substance. Reducing the concentration of the active substance implies that the patient does not receive the required dose for treatment and the success of therapy is in doubt. The division of amlodipine tablets is economically convenient, but is a practice that should be avoided and not advised by the healthcare providers.


2021 ◽  
pp. 3-10
Author(s):  
М. Х. Рахімова ◽  
С. М. Мусозода ◽  
О. С. Шпичак

The diabetes is one of the most pressing medical and social problems in the health care system of most countries, including Tajikistan. According to experts from the International Health Organization, this disease is a problem for all segments of the population and age groups. In this regard, the modernization of the price regulation system in order to provide consumers with highly effective, harmless and affordable antidiabetic drugs is an urgent task of the health care and public protection system of the Republic of Tajikistan. The aim of the work is to study the range of drugs registered in the Republic of Tajikistan for the treatment of diabetes. The object of the study were scientific sources, statistics, price indicators, official websites of authorized publications on registered medicines. The research was conducted using methods of analysis, systematization and generalization, mathematical and statistical calculations. The range of oral hypoglycemic drugs presented on the pharmaceutical market of the Republic of Tajikistan was studied and the analysis of the pharmaceutical market of oral antidiabetic drugs by countries-manufacturers, dosage forms, groups of anatomical-therapeutic-chemical (ATC) classification was carried out. On March 1, 2021, 70 trade names of oral hypoglycemic drugs were registered. The range of drugs is mainly represented by drugs from the group of sulfanylurea derivatives (21 trade names of drugs or 30% of the total number of drugs in this group), as well as drugs from the group of biguanide derivatives (17 trade names of drugs or 24.28% of their total quantity). In the structure of deliveries of oral hypoglycemic drugs the leading positions are occupied by India – 31.25% (15 LP), Pakistan – 22.91% (11 LP), Ukraine – 14.58% (7 LP), Belarus and Germany – 6.25% each. (3 LP each). Registered 8 names of insulin preparations for injection in the form of vials (5 ml and 10 ml) and cartridges made in Ukraine («Farmak», «Indar») and India («Wockhardt Limited») and in pre-filled syringe pens produced by the company «Indar», Ukraine.


2021 ◽  
Vol 9 (1) ◽  
pp. 21-29
Author(s):  
I.A. Grigorieva ◽  
G.Kh. Garifullina ◽  
S.N. Egorova

atients with cardiovascular diseases need systematic monitoring of the main parameters of the cardiovascular system on an outpatient basis using special medical devices. The aim of the study is to conduct an assortment analysis of medical devices intended for use at home by patients with cardiovascular diseases. Materials and methods: The objects of the study were clinical recommendations for the treatment of diseases of the cardiovascular system (12); State Register of Medical Devices of the Russian Federation; Internet sites of pharmacy chains of the Republic of Tatarstan (5), sites of Internet pharmacies (1); data of the reference service “003” State Unitary Enterprise “Medical equipment and pharmacy of Tatarstan”. The work uses the methods of content analysis, logical, structural, graphic analysis. Price segmentation was carried out using the Sturgess grouping method. Results. An analysis of clinical guidelines for the prevention and treatment of diseases of the cardiovascular system was carried out to identify the main control parameters required on an outpatient basis. The groups of medical devices used by patients on their own have been determined: tonometers, pulse oximeters and diagnostic tests. The analysis of the State Register of Medical Products and Pharmacy Assortment of the Republic of Tatarstan was carried out in order to identify the availability of medical products to the population. Price segmentation of the studied groups of medical devices was carried out in order to determine consumer opportunities; the indicators of the completeness of the assortment were calculated. A wide range of tonometer models is presented in pharmacies of the Republic of Tatarstan. More than 60% of mechanical and automatic blood pressure monitors are in the low segment; the indicator of the completeness of the assortment Kp = 0.83, which allows satisfying the needs of patients. 50% of the assortment group “pulse oximeters” sold from pharmacies belongs to the low price segment; assortment completeness indicator Kp = 0.29. Diagnostic tests implemented in the Republic of Tatarstan are represented by express tests for the determination of ketones in blood and urine; assortment completeness indicator Kp = 0.31. The price segmentation of test systems is largely determined by the need to use additional instruments (analyzers). 75% of the total number of express tests presented on the pharmaceutical market of the Republic of Tatarstan belong to the middle price segment. Conclusions. As of March 2021, 950 medical devices used in the diagnosis and treatment of cardiovascular diseases were registered on the domestic market. At the same time, 22.6% can be used at home and are sold to the population by pharmacy organizations. For self-monitoring of indicators of the cardiovascular system on an outpatient basis, tonometers, test systems and heart rate monitors are used. Their share of the total number of registered medical devices used in the diagnosis and treatment of cardiovascular diseases is 17%. The price segmentation of the studied groups of medical devices indicates the availability of their purchase by customers with high and medium paying capacity. The prospects for expanding the range of medical products for independent use by patients with cardiovascular diseases in the regional pharmaceutical market have been identified.


Sign in / Sign up

Export Citation Format

Share Document